Adamis Pharmaceuticals Corp (NASDAQ: ADMP) is excited about its rise in stock that stood at 55.7%. Before that, the company stock had declined by 11.50% to settle at $1.00. This “climb,” coupled with its Covid-19 therapy endeavors that seem to be nearing the finish line, continues to inspire hope among […]